Details of the Drug Reposition

General Information of This Drug (ID: DMTLR6Y)

Drug Name	3K3A-APC DMTLR6Y

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Ischemic stroke	DISYV7YJ	8B11.5Z	Phase 2	[1]
Cerebrovascular ischaemia	DISFSDLO	8B1Z	Phase 2	[2]
------------------------------------------------------------------------------------

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2	ClinicalTrials.gov (NCT02222714) Safety Evaluation of 3K3A-APC in Ischemic Stroke. U.S. National Institutes of Health.